Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DIOPTIC Pharmaceuticals Inc. is a specialized Canadian pharmaceutical company headquartered in Toronto, Ontario, focused on the ophthalmic market. The company manufactures and distributes a range of vision care products, including diagnostic agents like fluorescein sodium strips (Diofluor) and therapeutic medications such as atropine, gentamicin, and prednisolone eye drops. DIOPTIC plays a critical role in the Canadian eye care sector, often collaborating with professional bodies like the Canadian Association of Optometrists to ensure the supply of essential diagnostic tools. As a commercial-stage manufacturer, the company provides high-quality, sterile pharmaceutical solutions used extensively in clinical and hospital settings for eye examinations and the management of ocular conditions. Its portfolio addresses a variety of needs, from diagnostic accuracy in surgical procedures to the treatment of bacterial infections and inflammatory eye diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DIOPTIC Pharmaceuticals.